These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 14569416)
61. Vascular endothelial growth factor-C expression and invasive phenotype in ovarian carcinomas. Ueda M; Hung YC; Terai Y; Kanda K; Kanemura M; Futakuchi H; Yamaguchi H; Akise D; Yasuda M; Ueki M Clin Cancer Res; 2005 May; 11(9):3225-32. PubMed ID: 15867217 [TBL] [Abstract][Full Text] [Related]
62. [Effect of silencing HIF-1alpha by RNA interference on expression of vascular endothelial growth factor in osteosarcoma cell line SaOS-2 under hypoxia]. Wu Q; Yang SH; Wang RY; Ye SN; Xia T; Ma DZ Ai Zheng; 2005 May; 24(5):531-5. PubMed ID: 15890092 [TBL] [Abstract][Full Text] [Related]
63. [Curcumin inhibits the expression of vascular endothelial growth factor and androgen-independent prostate cancer cell line PC-3 in vitro]. Deng G; Yu JH; Ye ZQ; Hu ZQ Zhonghua Nan Ke Xue; 2008 Feb; 14(2):116-21. PubMed ID: 18390174 [TBL] [Abstract][Full Text] [Related]
64. Angiogenic mediators of the angiopoietin system are highly expressed by CD10-positive lymphoma cells in angioimmunoblastic T-cell lymphoma. Konstantinou K; Yamamoto K; Ishibashi F; Mizoguchi Y; Kurata M; Nakagawa Y; Suzuki K; Sawabe M; Ohta M; Miyakoshi S; Crawley JT; Kitagawa M Br J Haematol; 2009 Mar; 144(5):696-704. PubMed ID: 19120365 [TBL] [Abstract][Full Text] [Related]
65. [Experimental study of anti-VEGF hairpin ribozyme gene inhibiting expression of VEGF and proliferation of ovarian cancer cells]. Yan RL; Qian XH; Xin XY; Jin M; Hui HX; Wang DT; Wang J Ai Zheng; 2002 Jan; 21(1):39-44. PubMed ID: 12500395 [TBL] [Abstract][Full Text] [Related]
66. Immunohistochemical study of VEGF, angiopoietin 2 and their receptors in the neovascularization following microinjection of C6 glioma cells into rat brain. Péoch M; Farion R; Hiou A; Le Bas JF; Pasquier B; Rémy C Anticancer Res; 2002; 22(4):2147-51. PubMed ID: 12174896 [TBL] [Abstract][Full Text] [Related]
67. MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells. Li Z; Hu S; Wang J; Cai J; Xiao L; Yu L; Wang Z Gynecol Oncol; 2010 Oct; 119(1):125-30. PubMed ID: 20624637 [TBL] [Abstract][Full Text] [Related]
68. Soluble FLT-1 expression suppresses carcinomatous ascites in nude mice bearing ovarian cancer. Hasumi Y; Mizukami H; Urabe M; Kohno T; Takeuchi K; Kume A; Momoeda M; Yoshikawa H; Tsuruo T; Shibuya M; Taketani Y; Ozawa K Cancer Res; 2002 Apr; 62(7):2019-23. PubMed ID: 11929819 [TBL] [Abstract][Full Text] [Related]
69. Localized expression of angiopoietin 1 and 2 may explain unique characteristics of the rat testicular microvasculature. Häggström Rudolfsson S; Johansson A; Franck Lissbrant I; Wikström P; Bergh A Biol Reprod; 2003 Oct; 69(4):1231-7. PubMed ID: 12773423 [TBL] [Abstract][Full Text] [Related]
70. Tumor vessel biology in pediatric intracranial ependymoma. Wagemakers M; Sie M; Hoving EW; Molema G; de Bont ES; den Dunnen WF J Neurosurg Pediatr; 2010 Apr; 5(4):335-41. PubMed ID: 20367336 [TBL] [Abstract][Full Text] [Related]
71. The temporal-spatial expression of VEGF, angiopoietins-1 and 2, and Tie-2 during tumor angiogenesis and their functional correlation with tumor neovascular architecture. Tse V; Xu L; Yung YC; Santarelli JG; Juan D; Fabel K; Silverberg G; Harsh G Neurol Res; 2003 Oct; 25(7):729-38. PubMed ID: 14579791 [TBL] [Abstract][Full Text] [Related]
72. Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions. Coffelt SB; Tal AO; Scholz A; De Palma M; Patel S; Urbich C; Biswas SK; Murdoch C; Plate KH; Reiss Y; Lewis CE Cancer Res; 2010 Jul; 70(13):5270-80. PubMed ID: 20530679 [TBL] [Abstract][Full Text] [Related]
73. Rat aorta-derived mural precursor cells express the Tie2 receptor and respond directly to stimulation by angiopoietins. Iurlaro M; Scatena M; Zhu WH; Fogel E; Wieting SL; Nicosia RF J Cell Sci; 2003 Sep; 116(Pt 17):3635-43. PubMed ID: 12876214 [TBL] [Abstract][Full Text] [Related]
74. [Synergic effects of the combination of VEGF-targeted shRNA and taxol on human prostate cancer DU145 both in vitro and in vivo]. Li BW; Zhang M; He HW; Zhang SH; Shao RG Yao Xue Xue Bao; 2009 Mar; 44(3):296-302. PubMed ID: 19449527 [TBL] [Abstract][Full Text] [Related]
75. A quantitative gene expression study suggests a role for angiopoietins in focal nodular hyperplasia. Paradis V; Bièche I; Dargère D; Laurendeau I; Nectoux J; Degott C; Belghiti J; Vidaud M; Bedossa P Gastroenterology; 2003 Mar; 124(3):651-9. PubMed ID: 12612904 [TBL] [Abstract][Full Text] [Related]
77. Angiopoietin-1 and vascular endothelial growth factor expression in human esophageal cancer. Nagata J; Kijima H; Hatanaka H; Tokunaga T; Kamochi J; Abe Y; Takagi A; Mine T; Yamazaki H; Nakamura M; Ueyama Y Int J Mol Med; 2002 Oct; 10(4):423-6. PubMed ID: 12239588 [TBL] [Abstract][Full Text] [Related]
78. Angiopoietin-1 and -2 exert antagonistic functions in tumor angiogenesis, yet both induce lymphangiogenesis. Fagiani E; Lorentz P; Kopfstein L; Christofori G Cancer Res; 2011 Sep; 71(17):5717-27. PubMed ID: 21778249 [TBL] [Abstract][Full Text] [Related]
79. [Impact of cyclin-dependent kinase inhibitor p27 on resistance of ovarian cancer multicellular spheroids to taxol]. Xing H; Li J; Gao QL; Wu JH; Gao C; Lu YP; Ma D Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(1):37-41. PubMed ID: 12757643 [TBL] [Abstract][Full Text] [Related]
80. Angiopoietin-2 promotes disease progression of neuroendocrine tumors. Detjen KM; Rieke S; Deters A; Schulz P; Rexin A; Vollmer S; Hauff P; Wiedenmann B; Pavel M; Scholz A Clin Cancer Res; 2010 Jan; 16(2):420-9. PubMed ID: 20068079 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]